Search

everythinglearnresearchcommunity

for

Search:↓

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

An integrative approach combining medical, nutritional, and lifestyle changes effectively manages female pattern hair loss.

People with androgenetic alopecia are more likely to have metabolic syndrome.

The dog likely has a canine alopecia X-like disorder.

The dog likely has a condition similar to Canine alopecia X.

Most non-medical students at Tarumanagara University have good knowledge and attitudes about PCOS.

Somatostatin analogues effectively manage ectopic ACTH syndrome when surgery isn't possible.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Netherton's syndrome is linked to high IgE levels and unique skin and hair symptoms, and may improve with ammonium lactate lotion and allergy management.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

PCOS is common among Indian women, often with metabolic issues, needing better management strategies.

Lifestyle changes, exercise, and antioxidants can help manage polycystic ovary syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.